Jinhui Xue

Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer

Cheng‐Bei Zhou, Siyuan Pan, Peng Jin et al. · Gastroenterology · 2022 · 93 citations · Full text

Fecal Signatures, Clinical Gastroenterology, Gastric Cancer +4

BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study

Yuxiang Ma, Yan Huang, Yuanyuan Zhao et al. · The Lancet Oncology · 2024 · 88 citations

Medicine, Immunology, Pathology +6

The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor

Xinru Chen, Xiangchan Hong, Gang Chen et al. · Translational Oncology · 2022 · 43 citations · Full text

A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial

Yuxiang Ma, Yunpeng Yang, Yan Huang et al. · Nature Medicine · 2025 · 41 citations · Full text

Rapid and Error-Free Site-Directed Mutagenesis by a PCR-Free <i>In Vitro</i> CRISPR/Cas9-Mediated Mutagenic System

Wenwen She, Jing Ni, Ke Shui et al. · ACS Synthetic Biology · 2018 · 35 citations

Icm System, In Vivo Gene Therapy, Natural Sciences +15